OPERON ELEVATEPLUS | SFDA REGISTRATION

SFDA Medical Device Registration & Saudi Market Access Consulting Service in Algeria

Operon Strategist provides end-to-end SFDA medical device registration consulting for manufacturers, exporters, and healthcare distributors in Algeria. We guide MedTech companies through risk classification (Classes A–D and IVDs), Saudi Authorized Representative (AR) appointment, technical file compilation per MDS-REQ 1, and GHAD portal submission—ensuring seamless Medical Device Marketing Authorization (MDMA) and rapid access to the Kingdom of Saudi Arabia.

Take the next step

Connect with our experts to discuss your next big medical device idea

Operon ElevatePlus
SFDA (Saudi Arabia) Registration Service Portfolio

Classification of medical devices and IVDs under SFDA risk classes (Class A–D)

Determination of applicable regulatory pathways and MDMA requirements

Regulatory roadmap aligned with SFDA guidelines and expectations

Guidance on selection and appointment of a Saudi-based Authorized Representative

Support with AR licensing, agreements, and compliance responsibilities

AR coordination for regulatory submissions and SFDA correspondence

Review and gap analysis of technical documentation against SFDA requirements

Preparation of regulatory dossiers including risk management, clinical evidence, and labeling

Support for conformity assessment and compliance alignment

MDMA application submission through SFDA regulatory portals

Management of regulatory queries and deficiency responses

Continuous tracking and coordination during SFDA review cycles

Post-market surveillance (PMS) and vigilance reporting support

License maintenance, renewals, and variation submissions

Regulatory support for product changes and additional listings

What Sets Us Apart

Global exposure, structured thinking, and execution-ready expertise

Experience with SFDA Registrations Across All Device Classes (A–D)

Support for Medical Devices & IVD Registrations in Saudi Arabia

In-Depth Knowledge of the MDMA Approval Process

Global Regulatory Support Across EU, US, GCC & APAC Markets

SFDA Medical Device Registration & GCC Market Strategy – We empower medical device and IVD companies in Algeria to achieve full compliance with the Saudi Food and Drug Authority (SFDA). Our services cover regulatory gap assessments, dual Arabic/English labeling harmonization, and post-market surveillance coordination—enabling confident expansion across Saudi healthcare markets while supporting audit readiness for Algerian ANPP (Agence Nationale des Produits Pharmaceutiques) dossiers.

Operon SFDA Regitstration Advantage

End-to-end regulatory support for achieving Medical Device Marketing Authorization (MDMA) from the Saudi Food and Drug Authority (SFDA), enabling compliant market entry for medical devices and IVDs in the Kingdom of Saudi Arabia (KSA)

Complete SFDA Registration Lifecycle Support

Authorized Representative (AR) Coordination & Management

Regulatory Documentation & Compliance Gap Analysis

Post-Registration Compliance & Surveillance Assistance

frequently asked questions

MDMA (Medical Device Marketing Authorization) is the mandatory license issued by the Saudi Food and Drug Authority (SFDA) allowing medical devices and IVDs to be legally imported, distributed, or sold in Saudi Arabia. Algerian manufacturers seeking to export medical technology to KSA must secure MDMA clearance prior to commercial shipment.

No. Under SFDA regulations, foreign manufacturers based outside Saudi Arabia (including Algeria) cannot submit applications directly. You must appoint an SFDA-licensed Saudi Authorized Representative (AR) to manage the GHAD portal submission, hold regulatory liability, and act as the official liaison with Saudi authorities.

All SFDA medical device registrations, establishment licensing, and MDMA applications are processed through the SFDA’s unified electronic portal called GHAD. Operon Strategist manages complete GHAD dossier compilation and query responses on behalf of Algerian exporters.

While Algeria’s ANPP (Agence Nationale des Produits Pharmaceutiques) operates its own national homologation process, submitting an technical dossier that holds valid SFDA approval, ISO 13485 QMS certification, and IMDRF-aligned risk management data significantly strengthens technical credibility during domestic ANPP reviews.

Yes. The SFDA mandates that medical device labeling and Instructions for Use (IFU) intended for lay users or home healthcare must be provided in Arabic (or bilingual Arabic/English). Professional-use devices used exclusively by healthcare personnel may be supplied in English, provided user consent and regulatory criteria are met.

Ready to Register Your Medical Device in Saudi Arabia

Talk to an SFDA registration expert

Please provide the following information and we’ll put you in touch with the right person.